Lung Cancer Clinical Trial:

"Patients treated with the cysteine-rich protein had a mean increase of 2.5% body weight while casein-treated patients lost 2.6%. Survival statistics were equally impressive: after one year, 80% of the Immunocal-fed patients survived, whereas fewer than half of the placebo group was still alive"【59:3†Immunotec Clinical Studies 2024.pdf†file-DvFueF2YVDPZR9FnD78RXG】

Laboratory Study on Liver Cancer Cells:

"Immunocal seemed to enhance the cytotoxicity of an anti-cancer drug by inducing significantly more apoptosis (cell death) in liver cancer cells. This increase in apoptotic cells was associated with depletion of glutathione within cancer cells, making them more vulnerable to chemotherapy"【59:9†Immunotec Clinical Studies 2024.pdf†file-DvFueF2YVDPZR9FnD78RXG

Colorectal Cancer Prehabilitation Studies:

Multiple studies have shown Immunocal supports better outcomes for colorectal cancer patients undergoing surgery, reducing complications and enhancing functional recovery【59:1†Immunotec Clinical Studies 2024.pdf†file-DvFueF2YVDPZR9FnD78RXG】

Multimodal Prehabilitation in Lung Cancer Surgery:

Demonstrated improved baseline functional capacity and postoperative outcomes【59:1†Immunotec Clinical Studies 2024.pdf†file-DvFueF2YVDPZR9FnD78RXG】

Whey Proteins in Cancer Prevention:

"Extensive literature indicates whey proteins, specifically cysteine-rich varieties like Immunocal, significantly bolster glutathione levels and enhance overall cancer prevention strategies"【59:1†Immunotec Clinical Studies 2024.pdf†file-DvFueF2YVDPZR9FnD78RXG】.